Zomacton Purple Book BLA 019774

BLA number
019774
Proprietary names
Zomacton
Proper names
somatropin
Applicant
Ferring Pharmaceuticals Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Zomactonsomatropin351(a)4.8MGFor InjectionSubcutaneousMulti-Dose VialDiscLicensed1995-05-25
002Zomactonsomatropin351(a)5MGFor InjectionSubcutaneousMulti-Dose VialRxLicensed2002-01-04
003Zomactonsomatropin351(a)10MGFor InjectionSubcutaneousMulti-Dose VialRxLicensed2012-03-07

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2023-06-01U001Zomacton351(a)DiscFerring Pharmaceuticals Inc.
2020-05-01R001Zomacton351(a)RxFerring Pharmaceuticals Inc.
2020-05-01R002Zomacton351(a)RxFerring Pharmaceuticals Inc.
2020-05-01R003Zomacton351(a)RxFerring Pharmaceuticals Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2023-06-01001Zomacton351(a)DiscLicensed1995-05-25
2020-05-01001Zomacton351(a)RxLicensed1995-05-25
2020-05-01002Zomacton351(a)RxLicensed2002-01-04
2020-05-01003Zomacton351(a)RxLicensed2012-03-07